Non, il est contre-indiqu chez les personnes ayant certains antcdents mdicaux, comme le cancer de la thyrode
Yes, patients may benefit as long as liver is not severely damaged since the liver has to process the glutathione being injected as well
The side effects reported most often with GLP-1 medications are gastrointestinal, including nausea, vomiting, diarrhea, and constipation
At the time of writing, retatrutide has not received regulatory approval for clinical use
Tesofensine lowers body weight mainly by reducing appetite, increasing satiety, and enhancing energy expenditure, making it a promising candidate for the pharmacological treatment of obesity 1-4
This is precisely why a personalized plan beats chasing headlines